Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors

Enrolling by invitationOBSERVATIONAL
Enrollment

660

Participants

Timeline

Start Date

October 26, 2023

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
RetinoblastomaNeurocognitive DysfunctionHealth-Related Behavior
Interventions
DIAGNOSTIC_TEST

Neuropsychological assesment

Estimated intelligence (subtasks of Wechsler Intelligence Scale for Children - Fifth edition -Dutch version \[WISC-V-NL\] or Wechsler Adult Intelligence Scale - Forth edition - Dutch version \[WAIS-IV-NL\]); Vienna reaction time; Rey auditory verbal learning test; Word fluency; Beery-Buktenica Developmental Test of Visual-Motor Integration, 6th Edition; Test of Everyday Attention for Children (TEA-Ch), subtask Score!/ or Test of Everyday Attention (TEA), subtask Elevator task; Trail making test; Word-color interference test

DIAGNOSTIC_TEST

Psychosocial functioning and quality of life (questionnaires)

Anxiety (PROMIS); Depression (PROMIS); Peer-interaction (PROMIS); Perceived neurocognitive functioning (PROMIS); Participation and activity (PAY-CY); Trauma (KJTS/PCL-5); Health related quality of life (PEDSQL)

DIAGNOSTIC_TEST

Parental psychosocial functioning (questionnaires)

Anxiety (PROMIS); Depression (PROMIS); Distress Thermometer-Parents (DT-P); Trauma (PCL-5)

Trial Locations (1)

1081 HZ

Amsterdam University Medical Center, Amsterdam

All Listed Sponsors
lead

Amsterdam University Medical Center

OTHER